Core Laboratories Inc 2026年季度报告

FORM 10-Q (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the quarterly period ended June 30, 2026 OR CORE LABORATORIES INC. (Exact name of registrant as specified in its charter) 98-1164194(I.R.S. Employer Identification No.) Delaware(State or other jurisdiction ofincorporation or organization) 6316 Windfern RoadHouston, TX(Address of principal executive offices) 77040(Zip Code) (713) 328-2673(Registrant's telephone number, including area code) None (Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Title of each classTradingSymbol(s)Name of each exchange on which registeredCommon Stock (par value $0.01)CLBNew York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has beensubject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was requiredto submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and"emerging growth company" in Rule 12b-2 of the Exchange Act. Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying withany new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ The number of shares of common stock of the registrant, par value $0.01 per share, outstanding at July 24, 2026 was 45,884,542. CORE LABORATORIES INC.FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2026 INDEX PART I - FINANCIAL INFORMATION Item 1.Financial StatementsConsolidated Balance Sheets at June 30, 2026 (Unaudited) and December 31, 20253Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2026 and 2025(Unaudited)4Consolidated Statements of Comprehensive Income for the Three and Six Months Ended June 30,2026 and 2025 (Unaudited)6Consolidated Statements of Changes in Equity for the Three and Six Months Ended June 30, 2026and 2025(Unaudited)7Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2026 and 2025(Unaudited)9Notes to the Interim Consolidated Financial Statements (Unaudited)10Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations20Item 3.Quantitative and Qualitative Disclosures About Market Risk34Item 4.Controls and Procedures34 PART II - OTHER INFORMATION Item 1.Legal Proceedings35Item 1A.Risk Factors35Item 2.Unregistered Sales of Equity Securities and Use of Proceeds35Item 5.Other Information35Item 6.Exhibits36Signature37 PART I - FINANCIAL INFORMATION CORE LABORATORIES INC.CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data) CORE LABORATORIES INC.CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data) CORE LABORATORIES INC.CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME(In thousands) CORE LABORATORIES INC.CONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands) CORE LABORATORIES INC.NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) 1. DESCRIPTION OF BUSINESS References to “Core Lab”, “Core Laboratories”, the “Company”, “we”, “our” and similar phrases are used throughout thisQuarterly Report on Form 10-Q (“Quarterly Report”) and relate collectively to Core Laboratories Inc. and its consolidatedsubsidiaries. We operate our business in two segments: (1) Reservoir Description and (2) Production Enhancement. These complementaryoperating segments provide different services and products and utilize different technologies for evaluating and improving reservoirperformance and increasing oil and gas recovery from new and existing fields. For a description of the types of services andproducts offered by these operating segments, see Note 15 - Segment Reporting. 2. SIGNIFICANT ACCOUNTING POLICIES UPDATE The accompanying unaudited interim consolidated financial statements include the accounts of Core Laboratories Inc. and itssubsidiaries for which we have a controlling voting interest and/or a controlling financial interest.